392 related articles for article (PubMed ID: 31136737)
1. ST2 and the ST2/IL-33 signalling pathway-biochemistry and pathophysiology in animal models and humans.
Pusceddu I; Dieplinger B; Mueller T
Clin Chim Acta; 2019 Aug; 495():493-500. PubMed ID: 31136737
[TBL] [Abstract][Full Text] [Related]
2. ST2 Signaling in the Tumor Microenvironment.
Chang CP; Hu MH; Hsiao YP; Wang YC
Adv Exp Med Biol; 2020; 1240():83-93. PubMed ID: 32060890
[TBL] [Abstract][Full Text] [Related]
3. Soluble ST2--analytical considerations.
Mueller T; Jaffe AS
Am J Cardiol; 2015 Apr; 115(7 Suppl):8B-21B. PubMed ID: 25697919
[TBL] [Abstract][Full Text] [Related]
4. Soluble ST2: A complex and diverse role in several diseases.
Homsak E; Gruson D
Clin Chim Acta; 2020 Aug; 507():75-87. PubMed ID: 32305537
[TBL] [Abstract][Full Text] [Related]
5. Cancer cell-derived interleukin-33 decoy receptor sST2 enhances orthotopic tumor growth in a murine pancreatic cancer model.
Takenaga K; Akimoto M; Koshikawa N; Nagase H
PLoS One; 2020; 15(4):e0232230. PubMed ID: 32340025
[TBL] [Abstract][Full Text] [Related]
6. IL-13 Controls IL-33 Activity through Modulation of ST2.
Zhang M; Duffen JL; Nocka KH; Kasaian MT
J Immunol; 2021 Dec; 207(12):3070-3080. PubMed ID: 34789557
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary Production of Soluble ST2 in Heart Failure.
Pascual-Figal DA; Pérez-Martínez MT; Asensio-Lopez MC; Sanchez-Más J; García-García ME; Martinez CM; Lencina M; Jara R; Januzzi JL; Lax A
Circ Heart Fail; 2018 Dec; 11(12):e005488. PubMed ID: 30562096
[TBL] [Abstract][Full Text] [Related]
8. The biology of ST2: the International ST2 Consensus Panel.
Pascual-Figal DA; Januzzi JL
Am J Cardiol; 2015 Apr; 115(7 Suppl):3B-7B. PubMed ID: 25665766
[TBL] [Abstract][Full Text] [Related]
9. Plasma Soluble ST2 Levels Are Higher in Neurodegenerative Disorders and Associated with Poorer Cognition.
Tan YJ; Siow I; Saffari SE; Ting SKS; Li Z; Kandiah N; Tan LCS; Tan EK; Ng ASL
J Alzheimers Dis; 2023; 92(2):573-580. PubMed ID: 36776067
[TBL] [Abstract][Full Text] [Related]
10. The Interleukin-33/ST2 Pathway Is Expressed in the Failing Human Heart and Associated with Pro-fibrotic Remodeling of the Myocardium.
Tseng CCS; Huibers MMH; van Kuik J; de Weger RA; Vink A; de Jonge N
J Cardiovasc Transl Res; 2018 Feb; 11(1):15-21. PubMed ID: 29285671
[TBL] [Abstract][Full Text] [Related]
11. IL-33 and Its Receptor ST2 after Inhaled Allergen Challenge in Allergic Asthmatics.
Mitchell PD; Salter BM; Oliveria JP; El-Gammal A; Tworek D; Smith SG; Sehmi R; Gauvreau GM; O Apos Byrne PM
Int Arch Allergy Immunol; 2018; 176(2):133-142. PubMed ID: 29694974
[TBL] [Abstract][Full Text] [Related]
12. Common genetic variation at the IL1RL1 locus regulates IL-33/ST2 signaling.
Ho JE; Chen WY; Chen MH; Larson MG; McCabe EL; Cheng S; Ghorbani A; Coglianese E; Emilsson V; Johnson AD; Walter S; Franceschini N; O'Donnell CJ; ; ; Dehghan A; Lu C; Levy D; Newton-Cheh C; ; Lin H; Felix JF; Schreiter ER; Vasan RS; Januzzi JL; Lee RT; Wang TJ
J Clin Invest; 2013 Oct; 123(10):4208-18. PubMed ID: 23999434
[TBL] [Abstract][Full Text] [Related]
13. Role of the IL-33/ST2L axis in colorectal cancer progression.
Akimoto M; Takenaga K
Cell Immunol; 2019 Sep; 343():103740. PubMed ID: 29329638
[TBL] [Abstract][Full Text] [Related]
14. [The physiologic and pathophysiologic role of stimulating growth factor ST2.].
Dyleva YA; Gruzdeva OV; Akbasheva OE; Uchasova EG; Barbarash OL
Klin Lab Diagn; 2017; 62(10):599-605. PubMed ID: 30821940
[TBL] [Abstract][Full Text] [Related]
15. The levels of soluble ST2 in sera and bullous fluid from patients with bullous pemphigoid.
Wakatabi K; Komine M; Meephansan J; Matsuyama Y; Tsuda H; Tominaga S; Ohtsuki M
Eur J Dermatol; 2012; 22(3):333-6. PubMed ID: 22494834
[TBL] [Abstract][Full Text] [Related]
16. Dysregulated Interleukin -33/ST2 Pathway Perpetuates Chronic Inflammation in Hashimoto's Thyroiditis.
Wang X; Shao X; Liu X; Qin Q; Xu J; Zhang JA
Endocr Metab Immune Disord Drug Targets; 2019; 19(7):1012-1021. PubMed ID: 30819087
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-33 and its Receptor in Pulmonary Inflammatory Diseases.
Zhao J; Zhao Y
Crit Rev Immunol; 2015; 35(6):451-61. PubMed ID: 27279043
[TBL] [Abstract][Full Text] [Related]
18. IL-33 signalling contributes to pollutant-induced allergic airway inflammation.
De Grove KC; Provoost S; Braun H; Blomme EE; Teufelberger AR; Krysko O; Beyaert R; Brusselle GG; Joos GF; Maes T
Clin Exp Allergy; 2018 Dec; 48(12):1665-1675. PubMed ID: 30159930
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-33 and Soluble ST2 Levels in Infants with Hypoxic-Ischemic Encephalopathy.
Hamano H; Takahashi K; Kimura S; Matsuguma C; Kaneyasu H; Fujimoto Y; Ohta N; Okada S; Hasegawa S
Neonatology; 2023; 120(3):353-362. PubMed ID: 36996771
[TBL] [Abstract][Full Text] [Related]
20. Dynamic observation of IL-33 and its receptors in HIV patients who received HAART.
He B; Zheng L; Zhou H; He Y; Chen Z; Xiao S; Wang H; Ling Y; Zheng Y
Cell Mol Biol (Noisy-le-grand); 2017 Mar; 63(3):73-77. PubMed ID: 28466817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
